NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors.
暂无分享，去创建一个
M. Weichenthal | J. Utikal | D. Schadendorf | P. Jansen | S. Ugurel | R. Gutzmer | E. Livingstone | P. Terheyden | R. Murali | A. Sucker | L. Zimmer | C. Pföhler | P. Mohr | F. Meier | K. Griewank | E. Dippel | A. Kreuter | A. Paschen | J. Ulrich | A. Zaremba | E. Hadaschik | C. M. Thielmann | Johanna Matull | G. Lodde | J. Kretz | I. Möller | R. Herbst | E. Chorti | Luisa Richter | Inga Möller